BlackRock, Inc. disposed of 19.60 million shares of CSPC PHARMA (stock code: 01093) on September 16, 2026, in an off-exchange transaction involving non-cash assets, by way of releasing a security interest.
Prior to the disposal, BlackRock, Inc.'s long position in CSPC PHARMA was 578.07 million shares, representing 5.02%; following the disposal, the holding changed to 558.47 million shares, with the long position ratio falling to 4.85%.